Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E9PK
|
||||
Former ID |
DNC004144
|
||||
Drug Name |
MOXONIDINE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alcohol use disorders [ICD9: 303; ICD10:F10.2] | Approved | [526626] | ||
Structure |
Download2D MOL |
||||
Formula |
C9H15Cl2N5O2
|
||||
Canonical SMILES |
CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC
|
||||
InChI |
1S/C9H12ClN5O/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9/h3-4H2,1-2H3,(H2,11,12,15)
|
||||
InChIKey |
WPNJAUFVNXKLIM-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 75438-57-2
|
||||
PubChem Compound ID | |||||
SuperDrug ATC ID |
C02AC05
|
||||
Target and Pathway | |||||
Target(s) | Alpha-2A adrenergic receptor | Target Info | Inhibitor | [534128] | |
Alpha-2C adrenergic receptor | Target Info | Inhibitor | [534128] | ||
Alpha-2B adrenergic receptor | Target Info | Inhibitor | [534128] | ||
PANTHER Pathway | Alpha adrenergic receptor signaling pathwayP00002:Alpha adrenergic receptor signaling pathway | ||||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP00002:Alpha adrenergic receptor signaling pathway | |||||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.